Form DEF 14A KODIAK SCIENCES INC. For: 22 April
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Kodiak Sciences Inc (KOD)
Assess today's live Kodiak Sciences Inc (KOD) share price, performance and insights using our live NASDAQ: KOD stock exchange data.
Analyse the historical data and Kodiak Sciences Inc share price performance charts on this page. Our technical summary section provides analysis on Kodiak Sciences share price buy/sell indicators using real-time data (or discuss the Kodiak Sciences (KOD) stock price today with other investors in the Kodiak Sciences NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ KOD share price (ISIN: US50015M1099) to enhance your trading decisions with our free investment tools and resources.
What Is the Kodiak Sciences Inc Share Price Today?
The Kodiak Sciences share price today is 43.700.
What Is the Stock Symbol for Kodiak Sciences Inc
The stock symbol (or 'ticker') for Kodiak Sciences Inc is "KOD."
What Stock Exchange Does Kodiak Sciences Inc Trade On?
Kodiak Sciences Inc is listed and trades on the NASDAQ stock exchange.
Is Kodiak Sciences Inc a Good Stock to Buy?
Determining whether Kodiak Sciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Kodiak Sciences Inc share price performance charts on this page. Our technical summary section provides analysis on Kodiak Sciences share price buy/sell indicators using real-time data (or discuss the Kodiak Sciences (KOD) stock price today with other investors in the Kodiak Sciences NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ KOD share price (ISIN: US50015M1099) to enhance your trading decisions with our free investment tools and resources.
What Is the Kodiak Sciences Inc Share Price Today?
The Kodiak Sciences share price today is 43.700.
What Is the Stock Symbol for Kodiak Sciences Inc
The stock symbol (or 'ticker') for Kodiak Sciences Inc is "KOD."
What Stock Exchange Does Kodiak Sciences Inc Trade On?
Kodiak Sciences Inc is listed and trades on the NASDAQ stock exchange.
Is Kodiak Sciences Inc a Good Stock to Buy?
Determining whether Kodiak Sciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
43.440
-1.400(-3.12%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
43.415
47.000
52 wk Range
2.810
47.842
KOD is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
43.41547.000
52 wk Range
2.81047.842
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
KOD Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
56.333
Upside
+29.68%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock price movements are quite volatile
- Form 13G Kodiak Sciences Inc. For: 2 April
- Investing.com
- Kodiak Sciences stock hits 52-week high at $45.73
- Investing.com
- Form DEF 14A KODIAK SCIENCES INC. For: 22 April
- Investing.com
- Kodiak Sciences stock hits 52-week high at $45.73
- Investing.com
- Kodiak Sciences CFO Borgeson sells $1.2m in shares
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases; and in Phase 3 clinical study for the treatment of diabetic retinopathy, wet age-related macular degeneration (AMD), retinal vein occlusion, and diabetic macular edema, as well as in Phase 2/3 clinical study to treat wet AMD. The company’s preclinical stage product candidate includes KSI-501, an anti- interleukin-6 (IL-6) and VEGF-trap bispecific antibody biopolymer conjugate for high prevalence retinal vascular diseases; and KSI-101 (KSI-501P), a bispecific protein targeting IL-6 and VEGF developed for patients who have retinal fluid and inflammation. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.
Kodiak Sciences Inc SWOT Analysis
Pipeline Promise | Explore Kodiaq Sciences' diverse eye disease treatment portfolio, including KSI-101, tarcocimab, and KSI-501, with key trial results expected in 2025-2026 |
Financial Hurdles | Delve into the company's financial challenges, with negative EPS forecasts and a declining stock price, balanced against its cash-rich balance sheet |
Market Positioning | Learn how Kodiaq Sciences aims to differentiate itself in the competitive biotech sector through innovative treatments and a new wearable OCT device |
Future Outlook | Analyst price targets range from $3 to $4, reflecting cautious optimism amid clinical trial uncertainties and potential market opportunities |
Compare KOD to Peers and Sector
Metrics to compare | KOD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipKODPeersSector | |
|---|---|---|---|---|
P/E Ratio | −12.1x | −3.4x | −0.4x | |
PEG Ratio | 0.42 | −0.05 | 0.00 | |
Price/Book | 17.7x | 3.3x | 2.6x | |
Price / LTM Sales | - | 58.3x | 3.1x | |
Upside (Analyst Target) | 30.8% | 172.2% | 47.4% | |
Fair Value Upside | Unlock | −1.0% | 7.0% | Unlock |
Analyst Ratings
6 Buy
1 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 56.333
(+29.68% Upside)
Earnings
Latest Release
31/03/2026
EPS / Forecast
-1.04 / -1.01
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Kodiak Sciences (NASDAQ: KOD) Share Price Today?
The Kodiak Sciences stock price today is 43.440 USD.
What Stock Exchange Does Kodiak Sciences (KOD) Trade On?
Kodiak Sciences is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Kodiak Sciences?
The stock symbol (also called a 'ticker') for Kodiak Sciences is "KOD."
What Is the Current Kodiak Sciences Market Capitalisation?
As of today, Kodiak Sciences (NASDAQ: KOD) market cap is 2.700B USD.
What Is Kodiak Sciences's (KOD) Earnings Per Share (TTM)?
The Kodiak Sciences EPS is currently -4.322 (Trailing Twelve Months).
When Is the Next Kodiak Sciences Earnings Date?
Kodiak Sciences's next earnings report will be released on 20/05/2026.
Is KOD a Buy or Sell From a Technical Analyst Perspective?
Based on today's Kodiak Sciences moving averages and other technical indicators, the daily buy/sell signal for KOD stock is Strong Buy.
How Many Times Has Kodiak Sciences Stock Split?
Kodiak Sciences has split 0 times. (See the KOD stock split history page for full effective split date and price information.)
How Many Employees Does Kodiak Sciences Have?
Kodiak Sciences has 124 employees, based on their latest Companies House report.
What is the current trading status of Kodiak Sciences (NASDAQ: KOD)?
As of 27/04/2026, Kodiak Sciences (KOD) is trading at a share price of 43.440 USD, with a previous close of 44.840 USD. The stock has fluctuated within a day range of 43.415 USD to 47.000 USD, while its 52-week range spans from 2.810 USD to 47.842 USD.
What Is Kodiak Sciences (KOD) Price Target According to Analysts?
The average 12-month price target for Kodiak Sciences is 56.333 USD, with a high estimate of 80 USD and a low estimate of 14 USD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +29.68% Upside potential.
What Is the KOD Premarket Price?
KOD's last pre-market stock price is 44.990 USD. The pre-market share volume is 2,180.000, and the stock has decreased by 0.150, or 0.330%.
What Is the KOD After Hours Price?
KOD's last after hours stock price is 44.850 USD, the stock has decreased by 0.010, or 0.020%.
Industry Spotlight
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.